Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate
2008-05-06
2008-05-06
Fetterolf, Brandon (Department: 1642)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
Reexamination Certificate
active
07368110
ABSTRACT:
Mesothelin ins a differentiation antigen present on the surface of ovarian cancers, mesotheliomas and several other types of human cancers. Because among normal tissues, mesothelin is only present on mesothelial cells, it represents a good target for antibody mediated delivery of cytotoxic agents. The present invention is directed to anti-mesothelin antibodies, including Fv molecules with particularly high affinity for mesothelin, and immunoconjugates employing them. Also described are diagnostic and therapeutic methods using the antibodies. The anti-mesothelin antibodies are well-suited for the diagnosis and treatment of cancers of the ovary, stomach, squamous cells, mesotheliomas and other malignant cells expressing mesothelin.
REFERENCES:
patent: 5320956 (1994-06-01), Willingham et al.
patent: 5498698 (1996-03-01), Yamaguchi et al.
patent: 5723318 (1998-03-01), Yamaguchi et al.
patent: 5747654 (1998-05-01), Pastan et al.
patent: 6083502 (2000-07-01), Pastan et al.
patent: 6153430 (2000-11-01), Pastan et al.
patent: 7081518 (2006-07-01), Pastan et al.
patent: WO 92 07081 (1992-04-01), None
patent: WO 9207081 (1992-04-01), None
patent: WO 9725068 (1997-07-01), None
patent: WO 97 34634 (1997-09-01), None
Chowdhury et al ((J. Mol. Biol 281:917-928, 1998).
Brinkman U et al.,International Journal of Cancer, (May 16, 1997) 71 (4) 638-44.
Chang , K. et al.,Cancer Research(Jan 1, 1992) 52 (1) 181-6.
Kuby, JanisW.H. Freeman and Company New York, United States of America, (1994, pp. 136-134).
Heidelberg,Database EMBL(EMPRO)EMBL(Mar. 10, 1998).
Chowdhury, P.S. et al.,Proceedings of the National Academy of Sciences of the United States of America, (Jan. 20, 1998) 95 (2) 669-74.
Chowdhury, P.S. et al.,Molecular Immunology, (Jan. 1997) 34 (1).
Chowdhury, P.S. et al.,Journal of Molecular Biology, (Sep. 4, 1998) 281 (5) 917-28.
Yamaguchi, Nozomi et al.; “A Novel Cytokine Exhibiting Megakaryocyte Potentiating Activity From a Human Pancreatic Tumor Cell Line HPC-Y5”; 1994,The Journal of Biological Chemistry, vol. 269, No. 2, pp. 805-808.
Chowdhury Partha S.
Pastan Ira H.
Fetterolf Brandon
The United States of America as represented by the Department of
Townsend and Townsend / and Crew LLP
LandOfFree
Antibodies, including Fv molecules, and immunoconjugates... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies, including Fv molecules, and immunoconjugates..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies, including Fv molecules, and immunoconjugates... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2766507